29632-82-4

Basic information

• Product Name: 1,2-BENZISOTHIAZOL-3(2H)-ONE, 5-BROMO, 1,1-DIOXIDE
• Synonyms: 5-bromobenzo[d]isothiazol-3(2H)-one 1,1-dioxide;5-bromo-2,3-dihydro-1,2-benzothiazole-1,1,3-trione;1,2-BENZISOTHIAZOL-3(2H)-ONE, 5-BROMO, 1,1-DIOXIDE;5-Bromo-1,2-benzisothiazol-3-one 1,1-dioxide;5-bromo-1,1-dioxo-1,2-dihydro-1λ6-benzo[d]isothiazol-3-one
• CAS NO: 29632-82-4
• Molecular Formula: C7H4BrNO3S
• Molecular Weight: 262.09
• Mol File: 29632-82-4.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• Density: 1.958g/cm³
• Refractive Index: 1.664
• PKA: 0.80±0.30(Predicted)
• CAS DataBase Reference: 1,2-BENZISOTHIAZOL-3(2H)-ONE, 5-BROMO, 1,1-DIOXIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-BENZISOTHIAZOL-3(2H)-ONE, 5-BROMO, 1,1-DIOXIDE(29632-82-4)
• EPA Substance Registry System: 1,2-BENZISOTHIAZOL-3(2H)-ONE, 5-BROMO, 1,1-DIOXIDE(29632-82-4)

Safety Data

• Hazardous Substances Data: 29632-82-4(Hazardous Substances Data)

Usage

General Description

1,2-Benzisothiazol-3(2H)-one, 5-bromo, 1,1-dioxide is a chemical compound with the molecular formula C7H4BrNO3S. It is a brominated derivative of benzisothiazolone, which is commonly used as a biocide and preservative in various industrial and household products. The presence of the bromine atom and the dioxide group provides this compound with enhanced antimicrobial and antifungal properties, making it an effective additive in paints, cleaning agents, and other consumer products. It acts by disrupting the cellular membranes of microorganisms, preventing their growth and proliferation. Due to its antimicrobial properties, this chemical is subject to regulatory restrictions and must be handled and used with caution to minimize potential health and environmental risks.

InChI:InChI=1/C7H4BrNO3S/c8-4-1-2-6-5(3-4)7(10)9-13(6,11)12/h1-3H,(H,9,10)

Upstream product

• 29632-80-2 5-bromo-3,3-difluoro-3H-benzo[c][1,2]oxathiole 1,1-dioxide 
• 116340-67-1 4-bromo-2-methyl-benzenesulfonamide 
• 52727-57-8 5-bromo-2-aminobenzoic acid methyl ester 
• 5794-88-7 5-Bromo-2-aminobenzoic acid 
• 139937-37-4 5-bromo-2-toluenesulfonyl chloride 
• 591-17-3 meta-bromotoluene 
• 736948-72-4 methyl 5-bromo-2-(chlorosulfonyl)benzoate 

Downstream Products

• 1254319-63-5 5-bromo-2-(methyl)-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide 
• 1352152-68-1 5-bromo-2,3-dihydro-benzo[d]isothiazole 1,1-dioxide 
• 29083-17-8 5-methoxysaccharin 

Relevant articles and documents

Preparation method and medical application of benzisothiazole and benzothiophene

The invention discloses a preparation method and medical application of benzisothiazole and benzothiophene, and telates to the field of pharmaceutical chemistry. According to the invention, benzisothiazole and benzothiophene are the first type of HIF-2 agonists; compared with a compound M1001 found by the applicant in the earlier stage, the invention has better HIF-2 agonist activity, and has remarkable enhancement activity on expression of mRNA and protein of EPO, VGEF, Glut1, NDRG1 and the like at the downstream of HIF-2, so that the invention can be used for preparing drugs for treating and/or preventing chronic kidney diseases/chronic renal anemia, dyslipidemia and high cholesterol caused by abnormal expression of HIF-2; and the method has a good industrialization prospect.

Novel compounds that are inhibitors of YAP/TAZ-TEAD interaction and their use in the treatment of malignant mesothelioma

These compounds are useful as inhibitors of the YAP/TAZ-TEAD interaction.

NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE

A compound of Formula I is provided: or pharmaceutically acceptable enantiomers, salts or solvates thereof. The 5 invention further relates to the use of the compounds of Formula I as TDO2 inhibitors. The invention also relates to the use of the compounds of Formula I for the treatment and/or prevention of cancer, neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease and Huntington's disease, chronic viral infections such as HCV and HIV, depression, and obesity. The invention also 10 relates to a process for manufacturing compounds of Formula I.